Sudden Infant Death Syndrome

Published on 25/03/2015 by admin

Filed under Pediatrics

Last modified 25/03/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 998 times

Chapter 367 Sudden Infant Death Syndrome

The sudden, unexpected death of an infant that is unexplained by a thorough postmortem examination, which includes a complete autopsy, investigation of the scene of death, and review of the medical history, constitutes sudden infant death syndrome (SIDS). An autopsy is essential to identify possible natural explanations for sudden, unexpected death such as congenital anomalies or infection and to diagnose traumatic child abuse (Tables 367-1, 367-2, 367-3). The autopsy typically cannot distinguish between SIDS and intentional suffocation, but the scene investigation and medical history may be of help if inconsistencies are evident.










From Kliegman RM, Greenbaum LA, Lye PS: Practical strategies in pediatric diagnosis and therapy, ed 2, Philadelphia, 2004, Elsevier Saunders, p 98.



Recurrent true sudden infant death syndrome




Pulmonary hypertension


See Table 367-2


Disorders of immune host defense


From Kliegman RM, Greenbaum LA, Lye PS: Practical strategies in pediatric diagnosis and therapy, ed 2, Philadelphia, 2004, Elsevier Saunders, p 101.


There are no autopsy findings pathognomonic for SIDS and no findings required for the diagnosis, although there are some common findings. Petechial hemorrhages are found in 68-95% of cases and are more extensive than in explained causes of infant mortality. Pulmonary edema is often present and may be substantial. The reasons for these findings are unknown.

SIDS victims have several identifiable changes in the lungs and other organs and in brainstem structure and function. Nearly 65% of SIDS victims have structural evidence of pre-existing, chronic low-grade asphyxia, and other studies have identified biochemical markers of asphyxia. SIDS victims have higher levels of vascular endothelial growth factor (VEGF) in the cerebrospinal fluid (CSF). These increases may be related to VEGF polymorphisms (see Genetic Risk Factors) or might indicate recent hypoxemic events, because VEGF is upregulated by hypoxia. Brainstem findings include a persistent increase of dendritic spines and delayed maturation of synapses in the medullary respiratory centers, and decreased tyrosine hydroxylase immunoreactivity and catecholaminergic neurons. Decreases in serotonin 1A (5-HT1A) and 5-HT2A receptor immunoreactivity have been observed in the dorsal nucleus of the vagus, solitary nucleus, and ventrolateral medulla, whereas increases are present in periaqueductal gray matter of the midbrain. The decreased immunoreactivity of receptors is accompanied by brainstem gliosis, and it is therefore unclear whether the decreases are secondary to hypoxia or ischemia or whether they reflect primary alterations in 5-HT metabolism or transport (see Genetic Risk Factors) (Table 367-4).

The ventral medulla has been a particular focus for studies in SIDS victims. It is an integrative area for vital autonomic functions including breathing, arousal, and chemosensory function. Quantitative 3-dimensional (3D) anatomic studies indicate that some SIDS infants have hypoplasia of the arcuate nucleus and up to 60% have histopathologic evidence of less extensive bilateral or unilateral hypoplasia. Considering the apparent overlap between putative mechanisms for SIDS and unexpected late fetal deaths, ∼30% of late unexpected and unexplained stillbirths also have hypoplasia of the arcuate nucleus.

Neurotransmitter studies of the arcuate nucleus have also identified receptor abnormalities in some SIDS infants that involve several receptor types relevant to state-dependent autonomic control overall and to ventilatory and arousal responsiveness in particular. These deficits include significant decreases in binding to kainate, muscarinic cholinergic, and 5-HT receptors. Studies of the ventral medulla have identified morphologic and biochemical deficits in 5-HT neurons. Immunohistochemical analyses have revealed an increased number of 5-HT neurons and an increase in the fraction of 5-HT neurons showing an immature morphology, suggesting a failure or delay in the maturation of these neurons. It is not known whether such deficits in ventral medullary 5-HT neurons are sufficient to result in fatal autonomic dysfunction. High neuronal levels of interleukin 1β (IL-1β) are present in the arcuate and dorsal vagal nuclei in SIDS victims compared to controls, perhaps contributing to molecular interactions affecting cardiorespiratory and arousal responses.

The neuropathologic data provide compelling evidence for altered 5-HT homeostasis, creating an underlying vulnerability contributing to SIDS. 5-HT is an important neurotransmitter and the 5-HT neurons in the medulla project extensively to neurons in the brainstem and spinal cord that influence respiratory drive and arousal, cardiovascular control including blood pressure, circadian regulation and non-REM sleep, thermoregulation, and upper airway reflexes. Medullary 5-HT neurons may be respiratory chemosensors and may be involved with respiratory responses to intermittent hypoxia and respiratory rhythm generation. Decreases in 5-HT1A and 5-HT2A receptor immunoreactivity have been observed in the dorsal nucleus of the vagus, solitary nucleus, and ventrolateral medulla. There are extensive serotoninergic brainstem abnormalities in SIDS infants, including increased 5-HT neuronal count, a lower density of 5-HT1A receptor-binding sites in regions of the medulla involved in homeostatic function, and a lower ratio of 5-HT transporter (5-HTT) binding density to 5-HT neuronal count in the medulla. Male SIDS infants have lower receptor-binding density than female SIDS infants. These findings suggest that the synthesis and availability of 5-HT is altered within 5-HT pathways and hence alters neuronal firing. These neuropathologic data could be explained by an increased number of 5-HT neurons, leading to an excess of extracellular 5-HT and secondary down-regulation of 5-HT1A receptors. It is also possible that 5-HT synthesis and/or release may be deficient, leading to a deficiency of extracellular 5-HT despite a compensatory overabundance of 5-HT neurons. Although the neuropathologic data thus do not clarify whether medullary 5-HT levels are increased or decreased in SIDS infants, the 5-HTT polymorphism data are consistent with decreased extracellular or synaptic 5-HT concentrations.

Environmental Risk Factors

Declines of 50% or more in rates of SIDS in the USA and around the world have occurred in the past decade, at least in part as a result of national education campaigns directed at reducing risk factors associated with SIDS. The reductions in risk appear to be related primarily to decreases in placing infants prone for sleep and increases in placing them supine. A number of other risk factors also have significant associations with SIDS (Table 367-5); although many are nonmodifiable and most of the modifiable factors have not changed appreciably, self-reported maternal smoking prevalence during pregnancy has decreased by 25% in the past decade.

Modifiable Risk Factors

Buy Membership for Pediatrics Category to continue reading. Learn more here